These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 1865658

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Disturbances of hemostasis in patients with liver cirrhosis (author's transl)].
    Langiewicz J.
    Przegl Lek; 1978; 35(2):307-10. PubMed ID: 652998
    [No Abstract] [Full Text] [Related]

  • 23. [Serum concentration and antiviral activity of interferon alpha in chronic hepatitis and liver cirrhosis].
    Levitan BN, Astakhin AV, Chishieva EM, Afanas'ev SS.
    Voen Med Zh; 2004 Feb; 325(2):60-6, 96. PubMed ID: 15101297
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Trofopar treatment of chronic liver diseases.
    Loghinov AS, Suhareva GV, Bendikov EA, Blok IE, Astasenkova CJ, Nicolaeva AP.
    Rom J Intern Med; 1991 Feb; 29(1-2):65-74. PubMed ID: 1947713
    [Abstract] [Full Text] [Related]

  • 26. [Significance of serum carnitine in patients with liver diseases].
    Lin XH, Jiao LL, Xu GB, Tian GS.
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):367-9. PubMed ID: 16732913
    [Abstract] [Full Text] [Related]

  • 27. [Procollagen type III peptides in chronic viral hepatitis].
    Laskus T, Cianciara J, Lupa E, Slusarczyk J, Babiuch L.
    Pol Tyg Lek; 2006 May; 46(14-16):266-7. PubMed ID: 1669048
    [Abstract] [Full Text] [Related]

  • 28. [Fibrinolysis in chronic liver diseases studied by in vitro blood coagulation tests].
    Pósán E, Tornai I, Udvardy M.
    Orv Hetil; 1994 Dec 18; 135(51):2821-4. PubMed ID: 7838517
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Monoclonal immunoglobulinopathy in chronic active hepatitis and liver cirrhosis].
    Aprosina ZG, Andreeva NE, Krel' PE, Guseĭnova LA, Chernokhvostova EV.
    Ter Arkh; 1990 Dec 18; 62(7):105-11. PubMed ID: 2251646
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Fibrinopeptide A in liver cirrhosis: evidence against a major contribution of disseminated intravascular coagulation to coagulopathy of chronic liver disease.
    Mombelli G, Fiori G, Monotti R, Haeberli A, Straub PW.
    J Lab Clin Med; 1993 Jan 18; 121(1):83-90. PubMed ID: 8426084
    [Abstract] [Full Text] [Related]

  • 33. Serum tumor markers in chronic liver disease.
    Kadayifci A, Simsek H, Savas MC, Toppare M.
    Neoplasma; 1996 Jan 18; 43(1):17-21. PubMed ID: 8843954
    [Abstract] [Full Text] [Related]

  • 34. Impact of viral hepatitis on apo- and lipoprotein status in blood.
    Irshad M, Dube R, Joshi YK.
    Med Princ Pract; 2007 Jan 18; 16(4):310-4. PubMed ID: 17541298
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. [Diagnostic significance of determining the blood content of lactic and uric acids in chronic liver lesions of alcoholic and viral etiologies].
    Loginov AS, Dzhalalov KD, Blok IuE.
    Ter Arkh; 1985 Jan 18; 57(9):87-91. PubMed ID: 4082057
    [Abstract] [Full Text] [Related]

  • 37. Hemorrheological changes in chronic hepatitis and liver cirrhosis and their relations to the syndromes differentiated by traditional Chinese medicine.
    Wang QM, Shi JZ.
    Chin Med J (Engl); 1990 Nov 18; 103(11):939-44. PubMed ID: 2125916
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.